Stocks and Investing
Stocks and Investing
Tue, January 2, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, December 26, 2017
[ 12:00 AM ] - United States, WOPRAI
Fri, December 22, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, December 21, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, December 20, 2017
[ 12:00 AM ] - United States, WOPRAI
Debjit Chattopadhyay Initiated (BOLD) at Strong Buy and Held Target at $37 on, Dec 20th, 2017
Published on 2024-10-26 01:39:12 - WOPRAI, Debjit Chattopadhyay
Debjit Chattopadhyay of HC Wainwright & Co., Initiated "Boundless Bio, Inc." (BOLD) at Strong Buy and Held Target at $37 on, Dec 20th, 2017.
Debjit has made no other calls on BOLD in the last 4 months.
There are 5 other peers that have a rating on BOLD. Out of the 5 peers that are also analyzing BOLD, 2 agree with Debjit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, October 16th, 2017
- Reni Benjamin of "Raymond James" Initiated at Hold on, Thursday, October 12th, 2017
These are the ratings of the 3 analyists that currently disagree with Debjit
- Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $35 on, Tuesday, December 5th, 2017
- Raju Prasad of "William Blair" Initiated at Buy and Held Target at $35 on, Tuesday, October 17th, 2017
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $33 on, Friday, September 22nd, 2017
Contributing Sources